PRIVACY POLICY

Thank you for visiting the Website (the “Site”) of Laureate Pharma, Inc. ( “Laureate Pharma”, “we” or “us”). Safeguarding the privacy of this Site’s users is important to Laureate Pharma. Any user who accesses all or any part of this Site agrees that such user is at least eighteen (18) years old and that such user has consented to this Privacy Policy and the Legal Terms and Conditions For Using This Site. Each time a user accesses our Site, our policies should be reviewed because we reserve the right to change them from time to time.

INFORMATION YOU PROVIDE

Our Policy recognizes two kinds of personal data that deserve varying levels of protection. “Personally-Identifiable Information” includes without limitation, names, addresses, e-mail addresses, billing information, and employment information. A subset of that category, “Sensitive Data”, deserves additional safeguards. Sensitive Data includes information such as Social Security numbers and personal financial data.

You do not have to give us Personally-Identifiable Information to visit our Site. However, we store information that users enter on our Site or provide us in any other way.

COLLECTION

Personally-Identifiable Information will only be collected to the extent that Laureate Pharma deems reasonably necessary to serve a legitimate business purpose. We may also automatically collect non-Personally-Identifiable Information such as the domain name from which users access the Internet, the date of users visit, and the pages that are visited. This information enables us to determine the number of visitors to the pages of our Site and how users access it, so that we can improve our Site for user’s needs.

For the purpose of determining the effectiveness of our Site, Laureate Pharma may hire certain organizations that collect, analyze and report on non-personally identifiable data or provide Site support services. To the extent possible, Laureate Pharma will require these organizations to conform to Laureate Pharma’s Privacy Policy.

This Site is not intended or designed to attract children under the age of 13. We do not knowingly collect personally identifiable data from Site visitors under the age of 13.

COOKIES

We may use “cookies”. “Cookies” are elements of data that a web site can send to a user’s browser and store on a user’s computer. Cookies do not contain Personally-Identifiable Information about a user. They are used to enhance navigation and functionality of the Site, and to let us know how visitors are using the Site, so that we can improve the Site and a user’s experience on it. Users do not have control over cookies. Most browsers can be set to notify a user when a cookie is being placed on its computer. A user can also set most browsers to refuse to accept cookies or a user can also erase cookies, although this may affect a user’s Internet experience.

EXTERNAL DISTRIBUTION / OPT OUT

Users who provide Laureate Pharma with Personally-Identifiable information will be given the opportunity to Opt Out and refuse permission for external distribution of their Personally-Identifiable Information by sending an email to our Privacy Officer at Internet.Privacy@laureatepharma.comwith the words “OPT OUT” in the subject area. (External distribution does not include certain limited distributions such as sharing Personally-Identifiable Information with an entity working on behalf of Laureate Pharma; transfer of Personally-Identifiable Information in conjunction with the sale or similar transfer of Laureate Pharma; or the disclosure of Personally-Identifiable Information in connection with legal proceedings, investigations of crimes or other wrongdoing. However, sharing Personally-Identifiable Information with an entity working on behalf of Laureate Pharma or transferring Personally-Identifiable Information in conjunction with the sale or similar transfer of the company is considered an “Onward Transfer” and will be handled as described below.)

SENSITIVE DATA

The collection and use of Sensitive Data carries with it special obligations and responsibilities in order to maintain the data’s security, integrity and privacy. Sensitive Data will not be sold, rented or otherwise made available for external distribution outside Laureate Pharma (although it may be made available through an Onward Transfer as described below).

ONWARD TRANSFER

The transfer of Personally-Identifiable Information to a third party in connection with a sale of assets of Laureate Pharma or a merger involving Laureate Pharma or the sharing of Personally-Identifiable Information with a third party working on behalf of Laureate Pharma shall only be to a third party that subscribes to appropriate procedures to help ensure that the information is used only for authorized purposes and by authorized persons in a manner consistent with the choices that borrowers and customers have made under this Policy, and that the security, integrity and privacy of the information is maintained. Please note that our Site may contain links to other web sites that have their own privacy policies and practices. While Laureate Pharma will employ appropriate procedures to help ensure that your information is used only for authorized purposes, Laureate Pharma cannot make any guarantees with respect to the actions or policies of such third parties.

SECURITY

While we will try to protect Personally-Identifiable Information we have collected and maintained, we do not guarantee the effectiveness of any of our security measures. We are not responsible for the security of any information transmitted via the Internet.

Laureate Pharma will permit only authorized employees, who are trained in the proper handling of customer information, to have access to such information. Employees who violate Laureate Pharma’s Privacy Policy will be subject to Laureate Pharma’s normal disciplinary process.

EMPLOYMENT INQUIRIES

We use the resumes and information submitted to us to determine whether or not a user’s employment inquiry will be given consideration for employment openings at Laureate Pharma. Such information and resumes are only distributed to Laureate Pharma and its recruiting agencies.

Contacting our Privacy Officer

If there are any questions about this Privacy Policy or how we protect privacy rights, if you want to change or access your Personally-Identifiable Information, or if you feel that Laureate Pharma is not abiding by this Privacy Policy, please e-mail our Privacy Officer at Internet.Privacy@laureatepharma.com. At any time, if you have any questions, comments or concerns about the information practices of this site, please contact us as follows:

Internet Administration: webter@laureatepharma.com
Technical: TechInq@laureatepharma.com
General Legal: LegInq@laureatepharma.com
Privacy: PrivacyInt@laureatepharma.com
Linking: LinkInq@laureatepharma.com

By using this Site and the contents and services available to you on our Site, you consent to our collection and use of your information as described above.

Pharmacy News

Laureate and ARIUS Cooperation

Princeton, NJ and Paris, France, March 27, 2008: Laureate Pharma, Inc., a full-function facility of biopharmaceutical development and protein manufacturing, claimed nowadays that it has signed a contract with Cytheris SA, a clinical phase of biopharmaceutical facility oriented on trials and development of new treatment for immune stimulation. According to the contract, Laureate will produce Cytheris’ lead product candidate, Interleukin-7 (IL-7), a complete glycated recombinant human protein and crucial growth-stimulating…

Laureate Announces Second Manufacturing Agreement with Cytheris

Princeton, NJ and Paris, France, March 27, 2008: Laureate Pharma, Inc., a full-function facility of biopharmaceutical development and protein manufacturing, claimed nowadays that it has signed a contract with Cytheris SA, a clinical phase of biopharmaceutical facility oriented on trials and development of new treatment for immune stimulation. According to the contract, Laureate will produce Cytheris’ lead product candidate, Interleukin-7 (IL-7), a complete glycated recombinant human protein and crucial growth-stimulating factor for…

Laureate Pharma Agreement with Alopexx Pharmaceuticals

Laureate To Manufacture Alopexx’s Product Candidate On April 10, 2008, Laureate Pharma, Inc., a large company engaged in biopharmaceutical development and protein production reported that it has concluded a contract manufacturing agreement with Alopexx Pharmaceuticals on the production of Alopexx’s mAb F598 antibody under cGMP conditions. This antibody will be used in clinical trials and also for fighting Staphylococcus aureus infections. The details of the agreement were not announced. “We are happy that Laureate…

Laureate Pharma Company – Press Release

FOR IMMEDIATE RELEASE Laureate Pharma Launches New Contract Manufacturing Venture Company offers services for development and manufacture of biopharmaceuticals and sustained-release products Princeton, NJ – May 21, 2002 – Laureate Pharma Company announces the launch of contract manufacturing services at its two sites in New Jersey. Biopharmaceutical development and manufacturing services will be provided at a cGMP manufacturing facility in Princeton, NJ. Services related to sustained release microsphere products will…

Laureate Pharma Extends its Agreement with Cytogen for Manufacture of PROSTASCINT®

Princeton, NJ – October 25, 2006: Laureate Pharma, Inc. announced today that it has renewed its agreement with Cytogen Corporation for the cGMP manufacture of ProstaScint®, Cytogen’s proprietary monoclonal antibody immunoconjugate that is used for imaging in patients diagnosed with prostate cancer. Under the agreement, Laureate will provide cGMP protein production, purification, conjugation of Cytogen’s proprietary linker chelator and aseptic filling services to support Cytogen’s commercial ProstaScint® requirements. Terms of…

Laureate Pharma & DrugAbuse Sciences – Press Release

FOR IMMEDIATE RELEASE Laureate Pharma and DrugAbuse Sciences Announce Commercial Manufacturing Services Agreement. Princeton, NJ – June 24, 2002 – Laureate Pharma L.P. and DrugAbuse Sciences, Inc. announce the initiation of a contract manufacturing agreement related to a sustained release microsphere product. Under the agreement, Laureate Pharma will provide manufacturing services for DrugAbuse Sciences’ Naltrexone Depot product, currently in clinical trials. Terms of the agreement were not disclosed. “We are…

LAUREATE PHARMA COMPLETES SALE OF TOTOWA, NJ OPERATIONS TO DISCOVERY LABORATORIES FOR $16.0 MILLION

Laureate’s Bioprocessing Facility at Princeton, NJ to be Expanded Princeton, NJ – January 3, 2006 – Laureate Pharma, Inc., a wholly-owned subsidiary of Safeguard Scientifics, Inc. (NYSE: SFE), announced today that it had completed the previously announced sale of its Totowa, NJ operations to Discovery Laboratories, Inc. (NASDAQ: DSCO) for $16.0 million in cash. Laureate Pharma, a provider of bioprocessing services to pharmaceutical and biopharmaceutical companies, conducts its principal operations…

Laureate Biopharma Appoints Ann M. Daus, Ph.D. Vice President, Quality

– Leads implementation of Laureate’s strategic quality plan – PRINCETON, N.J., March 16, 2011 — Laureate Biopharmaceutical Services, Inc., a full-service biopharmaceutical contract development and manufacturing organization, today announced the appointment of Ann M. Daus, Ph.D, as Vice President, Quality. Dr. Daus will lead the implementation of Laureate’s strategic quality plan, recruit new leaders to supplement the quality management team, lead the strategic expansion of testing services and improve companywide…

Laureate Pharma Honored as Emerging Life Sciences Company of the Year

Laureate recognized for its business growth, leadership team and service innovation by the Eastern Technology Council Princeton, NJ, November 20, 2008: Laureate Pharma, Inc., a full-service biopharmaceutical development and protein production company, today announced that it has been named the “Emerging Life Science Company of the Year” by The Eastern Technology Council, the largest technology and life sciences trade association in the greater Philadelphia, PA region. The company was honored…

Laureate Pharma Announces Manufacturing Agreement with Alopexx Pharmaceuticals, LLC

Laureate To Manufacture Alopexx’s Product Candidate Princeton, NJ, April 10, 2008: Laureate Pharma, Inc., a full-service biopharmaceutical development and protein production company, today announced that it has entered into a cGMP contract manufacturing agreement with Alopexx Pharmaceuticals, LLC. According to the agreement, Laureate will produce Alopexx’s mAb F598 antibody under cGMP conditions. This antibody is planned for use in clinical trials, and later for commercial production for the treatment and…

Laureate Announces Manufacturing Agreement with ARIUS for Trop-2 Targeting Antibody

Laureate to Manufacture ARIUS’ Product Candidate Trop-2 Signal Transduction Antibody Princeton, NJ, January 31, 2008: Laureate Pharma, Inc., a full-service biopharmaceutical development and protein production company, today announced that it has entered into a cGMP contract manufacturing agreement with ARIUS Research, Inc., a biotechnology company focused on discovering and developing the next wave of antibody therapeutics to treat cancer and other diseases, for its Trop-2 Signal Transduction Antibody Program. Laureate…

LAUREATE PHARMA ANNOUNCES AGREEMENT WITH TRUBION PHARMACEUTICALS

LAUREATE TO MANUFACTURE TRUBION’S TRU-016 PRODUCT CANDIDATE Princeton, NJ, January 30, 2007: Laureate Pharma, Inc., a full-service biopharmaceutical development and protein production company, today announced it has entered into an agreement to produce Trubion Pharmaceuticals, Inc.’s TRU-016, a novel protein for the treatment of non-Hodgkin’s lymphoma (NHL) and chronic lymphocytic leukemia (CLL). Terms of the manufacturing agreement were not disclosed. Trubion’s TRU-016 program targets CD37, an antigen present on B…